We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$295B
AUM Growth
-$3.08B
Cap. Flow
-$7.58B
Cap. Flow %
-2.57%
Top 10 Hldgs %
30.42%
Holding
3,298
New
67
Increased
918
Reduced
1,605
Closed
77

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.6B
2
DIS icon
Walt Disney
DIS
+$795M
3
IDXX icon
Idexx Laboratories
IDXX
+$692M
4
ZTS icon
Zoetis
ZTS
+$640M
5
MSFT icon
Microsoft
MSFT
+$615M

Sector Composition

Rank Sector Weight
1 Technology 29.02%
2 Healthcare 12.31%
3 Consumer Discretionary 11.7%
4 Financials 11.01%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIM
3101
Eaton Vance Municipal Bond Fund
EIM
$493M
$124K ﹤0.01%
11,970
AIRS icon
3102
AirSculpt Technologies
AIRS
$322M
$123K ﹤0.01%
23,740
BLUE
3103
DELISTED
bluebird bio
BLUE
$123K ﹤0.01%
14,723
-4
-0% -$35
THRD
3104
DELISTED
Third Harmonic Bio
THRD
$123K ﹤0.01%
11,930
AOMR
3105
Angel Oak Mortgage REIT
AOMR
$223M
$120K ﹤0.01%
12,980
MLCO icon
3106
Melco Resorts & Entertainment
MLCO
$2.18B
$120K ﹤0.01%
20,707
-2,350
-10% -$15.8K
ALXO icon
3107
ALX Oncology
ALXO
$268M
$120K ﹤0.01%
71,730
SVM
3108
Silvercorp Metals
SVM
$2.07B
$119K ﹤0.01%
39,800
ASTL icon
3109
Algoma Steel
ASTL
$457M
$119K ﹤0.01%
12,180
QUAD icon
3110
Quad
QUAD
$435M
$115K ﹤0.01%
16,540
-199,605
-92% -$1.35M
CHPT icon
3111
ChargePoint
CHPT
$137M
$115K ﹤0.01%
5,355
-16,894
-76% -$418K
BBCP icon
3112
Concrete Pumping Holdings
BBCP
$518M
$115K ﹤0.01%
17,200
-870
-5% -$5.35K
CURV icon
3113
Torrid Holdings
CURV
$263M
$113K ﹤0.01%
21,600
KYTX icon
3114
Kyverna Therapeutics
KYTX
$446M
$112K ﹤0.01%
30,010
OCGN icon
3115
Ocugen
OCGN
$416M
$112K ﹤0.01%
138,730
RSVR icon
3116
Reservoir Media
RSVR
$731M
$110K ﹤0.01%
12,180
IAUX
3117
i-80 Gold Corp
IAUX
$1.11B
$109K ﹤0.01%
225,640
-43,530
-16% -$35.2K
TGB
3118
Trekor Metals
TGB
$2.5B
$108K ﹤0.01%
55,460
SGHT icon
3119
Sight Sciences
SGHT
$289M
$107K ﹤0.01%
29,280
LXEO icon
3120
Lexeo Therapeutics
LXEO
$349M
$105K ﹤0.01%
15,970
NOTE
3121
DELISTED
FiscalNote
NOTE
$101K ﹤0.01%
7,883
PANL icon
3122
Pangaea Logistics
PANL
$493M
$98.9K ﹤0.01%
18,450
INZY
3123
DELISTED
Inozyme Pharma
INZY
$96.9K ﹤0.01%
34,990
MAMA icon
3124
Mama's Creations
MAMA
$827M
$96.7K ﹤0.01%
12,150
ALTI icon
3125
AlTi Global
ALTI
$404M
$96.4K ﹤0.01%
21,860

Similar funds

AllianceBernstein's Q4 2024 Portfolio in Review

As of Q4 2024, AllianceBernstein held 3,298 positions worth $295B, down 1% from $298B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.4%. AllianceBernstein opened 67 new positions and exited 77, leaving the 3,298-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AllianceBernstein's largest Q4 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,000,000 shares worth $157M.
  • AllianceBernstein added most to Cboe Global Markets in Q4 2024, an estimated $1.07B increase.
  • AllianceBernstein's biggest Q4 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $1.6B.
  • AllianceBernstein fully exited iShares US Treasury Bond ETF in Q4 2024, selling an estimated $176M.
  • AllianceBernstein's ten largest holdings make up 30% of its $295B portfolio in Q4 2024.
  • AllianceBernstein opened 67 new positions and closed 77 in Q4 2024.
  • AllianceBernstein's portfolio value fell 1% quarter-over-quarter to $295B.

Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.